These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19903297)

  • 1. Regulating blood manufacturing software: report of a conference.
    Macpherson J; Kochman S; McCullough J
    Transfusion; 2009 Nov; 49(11):2490-4. PubMed ID: 19903297
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to manufacturers of blood establishment computer software products--FDA. Notice.
    Fed Regist; 1994 Aug; 59(168):44991-2. PubMed ID: 10136917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA NPRM would standardize blood labeling to permit inventory automation.
    McNeal BM
    Health Law Vigil; 1980 Dec; 3(24):6-7. PubMed ID: 10248995
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood investigation.
    AIDS Policy Law; 1996 May; 11(9):12. PubMed ID: 11363471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological products; blood specificity designators; technical amendments--FDA. Final rule; technical amendments.
    Fed Regist; 1994 May; 59(87):23636-7. PubMed ID: 10184096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal and regulatory problems facing blood suppliers.
    Sazama K
    Healthspan; 1989 Sep; 6(8):8-14. PubMed ID: 10295543
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA & clinical software vendors: a line in the sand?
    Schneider P
    Healthc Inform; 1996 Jun; 13(6):100-2, 104, 106. PubMed ID: 10161397
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in blood supply safety.
    Revelle M
    FDA Consum; 1995 Apr; 29(3):21-4. PubMed ID: 10141840
    [No Abstract]   [Full Text] [Related]  

  • 10. Impending FDA regulations of healthcare software. First stop: blood banking. Interview by Bill W. Childs.
    Marrazzo J
    US Healthc; 1988 Nov; 5(11):17-8. PubMed ID: 10291018
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-referencing of ISO-9000 and regulatory quality systems at blood centers.
    Healy-Collier K
    Top Health Inf Manage; 1998 May; 18(4):32-8. PubMed ID: 10179274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in transfusion medicine. Blood banks should use good manufacturing practices and the pharmaceutical manufacturing approach [corrected].
    Miller WV
    Transfusion; 1993 May; 33(5):435-8. PubMed ID: 8488549
    [No Abstract]   [Full Text] [Related]  

  • 13. Food and Drug Administration regulation of blood bank software: the new regulatory landscape for blood establishments and their vendors.
    Weeda DF; O'Flaherty NF
    Transfusion; 1998 Jan; 38(1):86-9. PubMed ID: 9482400
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C screening and notification: hospitals under new FDA regulations.
    Thomas M; Favata-Bosh DM
    QRC Advis; 1999 Jan; 15(3):1-5. PubMed ID: 10345516
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory and legislative issues in transfusion medicine.
    McCurdy K; Otter J
    Clin Lab Med; 1992 Dec; 12(4):835-44. PubMed ID: 1286568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Develop a useful donor-screening process.
    Harty-Golder B
    MLO Med Lab Obs; 2003 Oct; 35(10):34. PubMed ID: 14571850
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical device software regulation: an industry perspective.
    Simons D
    Food Drug Law J; 1997; 52(2):189-92. PubMed ID: 10557558
    [No Abstract]   [Full Text] [Related]  

  • 19. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Aug; 66(151):40886-90. PubMed ID: 11732557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressure grows over US blood ban.
    Goodman S
    Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.